drugset
drugset / Trial / NCT04444427

Evaluation of GLR2007 for Advanced Solid Tumors

NCT04444427 ↗

Phase 1/2 Completed 19 enrolled Gan and Lee Pharmaceuticals, USA
Non-randomizedSequentialOpen-labelTreatment

Summary

Evaluation of GLR2007 for Advanced Solid Tumors

Timeline

Start
2020-07-15
Primary completion
2022-07-29
Completion
2022-07-29

Drugs

EvaluationDrugModalityDoseRoute
Subject GLR2007 Unknown — Oral

Indications

glioblastoma non-small cell lung carcinoma